What are the differential diagnoses for hepatosplenomegaly?

Differential Diagnosis of Hepatosplenomegaly

The differential diagnosis of hepatosplenomegaly is broad and must be systematically approached by categorizing causes into infectious, metabolic (particularly lysosomal storage diseases), hematologic/neoplastic, congestive, and inflammatory etiologies, with the specific pattern of presentation, age, and associated clinical features guiding the diagnostic workup.

Primary Diagnostic Categories

Lysosomal Storage Diseases (LSDs)

These are critical metabolic causes that must be considered, especially when other common etiologies are excluded 1:

• Gaucher disease - Most common LSD with distinct hepatosplenomegaly
• Niemann-Pick disease types A, B, and C (Acid Sphingomyelinase Deficiency - ASMD) - Presents with massive splenomegaly (often >10x normal), hepatomegaly, mixed dyslipidemia (severely decreased HDL cholesterol), thrombocytopenia, and elevated transaminases 1
• Lysosomal acid lipase deficiency (LALD) - Also known as cholesterol ester storage disease (CESD) or Wolman disease
• GM1 and GM2 gangliosidosis, Farber disease, mucopolysaccharidoses - Typically have milder or absent hepatosplenomegaly compared to above 1

Key diagnostic clue: Elevated plasma chitotriosidase should immediately alert you to the presence of an LSD 2

Infectious Causes

Visceral Leishmaniasis (VL) - Critical treatable infection 3:

• Chronic fever, weight loss, splenomegaly, pancytopenia, hypoalbuminemia
• Elevated acute inflammatory markers and liver enzyme abnormalities
• Hyperpigmentation (in persons from India/Bangladesh)
• Acute differential: malaria, typhoid fever, typhus, acute Chagas disease, acute schistosomiasis, miliary tuberculosis, amebic liver abscess
• Chronic differential: miliary tuberculosis, brucellosis, prolonged/recurrent Salmonella infections, subacute bacterial endocarditis, disseminated fungal diseases (histoplasmosis), hepatosplenic schistosomiasis with portal hypertension

Other infectious considerations 4:

• Hepatosplenic candidosis (develops after neutrophil recovery with persistent fever, increased alkaline phosphatase)
• Systemic fungal infections in immunocompromised hosts
• Chronic viral hepatitis B/C

Hematologic/Neoplastic Causes 3

• Lymphoma
• Leukemia
• Myeloproliferative diseases
• Hemophagocytic lymphohistiocytosis (HLH) - presents with hepatosplenomegaly, ascites, gallbladder wall thickening, increased periportal echogenicity, lymphadenopathy, pleural effusion 5, 6

Primary Hepatic Diseases 1, 7

• Fatty liver disease (NAFLD/NASH)
• Autoimmune hepatitis
• Chronic hepatitis B-related disease
• Cryptogenic cirrhosis
• Primary biliary cholangitis
• Primary sclerosing cholangitis (PSC)

Vascular/Congestive Causes 8

• Idiopathic non-cirrhotic portal hypertension (INCPH) - characterized by:
  • Splenomegaly/hypersplenism with esophageal varices
  • Normal liver function initially
  • Patent portal and hepatic veins
  • Associated with thrombophilia (40% prevalence), immunological disorders, specific medications (azathioprine, didanosine), HIV infection
• Portal vein thrombosis
• Budd-Chiari syndrome
• Congestive heart failure

Inflammatory/Autoimmune Causes

• Adult-onset Still's disease - intermittent fever, evanescent rash, arthralgia/arthritis, lymphadenopathy, hepatosplenomegaly, markedly elevated ferritin and CRP 9
• Sarcoidosis
• Rheumatoid arthritis with Felty syndrome
• Macrophage activation syndrome (MAS) - particularly in context of juvenile dermatomyositis; presents with fever, cytopenia, hyperferritinemia, hemophagocytosis 6

Other Metabolic/Genetic Causes 1

• Congenital hepatic fibrosis
• Lysinuric protein intolerance
• Mevalonic aciduria
• Transaldolase deficiency

Age-Specific Considerations

Pediatric presentations 10, 11:

• Wolman disease (infantile form of LALD) - dramatic hepatosplenomegaly in infancy, now treatable with enzyme replacement therapy
• Infantile neurovisceral ASMD (NPD A) - onset by 3 months, death typically before 3 years
• Infectious, metabolic, and neoplastic causes are most common
• Psychomotor retardation, pallor, jaundice, and bleeding are common associated findings

Adult presentations 2:

• Chronic visceral ASMD (NPD B) - may not be diagnosed until adulthood despite childhood onset
• CESD/LALD
• Gaucher disease
• Fabry disease (though liver typically not affected)

Critical Diagnostic Workup Algorithm

Initial History Red Flags

• Age of onset and progression timeline
• Ethnicity/country of birth (hepatitis B/C, leishmaniasis risk)
• Travel history and tick bites
• Family history (LSDs, autoimmune diseases)
• Developmental delays or neurologic symptoms (suggests neurovisceral LSDs)
• Inflammatory bowel disease history (suggests PSC)
• Features of metabolic syndrome
• Drug history including immunosuppressants

Physical Examination Specifics 12

• Measure liver span at mid-clavicular line (hepatomegaly defined as enlargement below this line)
• Palpable spleen (splenomegaly has 93% sensitivity for advanced disease)
• Signs of chronic liver disease
• Neurologic examination (cherry red spot in ASMD, ataxia, developmental delays)
• Skin examination (heliotrope rash, evanescent rash with fever)

Laboratory Testing Strategy

Core panel 7:

• Complete blood count with differential (cytopenia suggests HLH, MAS, or hypersplenism)
• Comprehensive metabolic panel including liver enzymes (AST, ALT, alkaline phosphatase, GGT, total/direct bilirubin)
• Albumin
• Platelet count
• Prothrombin time/INR
• Hepatitis B surface antigen and hepatitis C antibody
• Autoimmune markers (ANA, anti-smooth muscle antibody, anti-mitochondrial antibody)
• Immunoglobulins

Critical specialized tests when LSDs suspected 1, 13:

• Plasma chitotriosidase (elevated in multiple LSDs)
• Ferritin (markedly elevated in ASMD, HLH, MAS, Still's disease)
• Lipid profile (severely decreased HDL cholesterol with elevated triglycerides suggests ASMD or LALD)
• Acid sphingomyelinase enzyme activity (for ASMD diagnosis)
• Lysosomal acid lipase enzyme activity (for LALD/Wolman disease)
• Molecular genetic testing (preferred confirmatory test over biopsy for LSDs)

Extended panel when core is unrevealing:

• Ceruloplasmin and 24-hour urine copper (Wilson's disease)
• Iron studies and ferritin (hemochromatosis)
• Bone marrow biopsy (hemophagocytosis, storage cells, malignancy)
• Liver biopsy with special stains

Imaging Approach 12

Abdominal ultrasound - first-line imaging:

• Assess liver and spleen size
• Evaluate for focal lesions
• Doppler to assess vascular patency
• Look for ascites, lymphadenopathy

Advanced imaging when indicated:

• MRI/MRCP for PSC, vascular abnormalities
• CT for detailed assessment of lymphadenopathy, masses
• Transient elastography or MR elastography for fibrosis assessment

Common Diagnostic Pitfalls

1. Assuming cirrhosis without biopsy - INCPH and LSDs can mimic cirrhosis radiologically but have patent vessels and different prognosis 8

2. Missing treatable LSDs - The collective incidence of LSDs is 1 in 5,000 live births; therapeutic advances make early diagnosis critical 13

3. Overlooking HLH/MAS - The combination of hepatosplenomegaly, fever, cytopenia, hyperferritinemia, and elevated liver enzymes should trigger immediate evaluation for hemophagocytosis 5, 6

4. Failing to consider leishmaniasis - In patients with appropriate travel/endemic exposure, VL must be excluded as it is treatable 3

5. Not checking chitotriosidase - This simple test can redirect the entire diagnostic approach toward LSDs 2

6. Repeating the same tests without investigation - 84% of abnormal liver enzymes remain abnormal at 1 month; 75% at 2 years. Determine the cause rather than simply repeating tests 7